INNERCAP Technologies Inc is a Drug Delivery Company with issued and pending US and foreign patents for it's multi-phase multi-compartment capsule delivery system for combination Rx pharmaceutical, bio-pharmaceutical, OTC pharmaceutical, medical foods and nutraceuticals. The delivery system overcomes difficult combination product issues by allowing actives to be formulated as liquids and solids in a single dosage form. This allows soluble or sensitive API's to be delivered as solids with poorly soluble API's formulated with liquids such as lipids to increase the bio-availability.